Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05824754 · ClinicalTrials.gov registry record · NA
An App to Reduce Cannabis Use Among Emerging Adults
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 122
- Enrollment target
NCT05824754: Completed NA study, sponsored by University of Michigan.
NCT05824754 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 122 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05824754, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 122 participants
- Enrollment target
Study Summary
This study is being completed to pilot prevention methods to promote wellness and reduce risky behaviors, including the use of substances such as cannabis. This study will help researchers learn about ways of delivering this information that is both appealing and helpful to young adults who use mobile apps.
Primary Outcome
% of participants who consented to the study who download the MiWaves app.
Interventions
- OTHER Just-In-Time-Adaptive-Intervention (JITAI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2024-02-21 |
| Est. Completion | 2024-05-28 |
| Phase | NA |
What the finished NCT05824754 record still lists
NCT05824754 is an interventional study that assigns participants to a tested intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which Just-In-Time-Adaptive-Intervention (JITAI) is the first listed.
NCT05824754 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05824754 about?
NCT05824754 is a clinical study titled "An App to Reduce Cannabis Use Among Emerging Adults". This study is being completed to pilot prevention methods to promote wellness and reduce risky behaviors, including the use of substances such as cannabis. This study will help researchers learn about ways of delivering this information that is both appealing and helpful to young adults who use mobi...
What is the current status of trial NCT05824754?
This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2024-02-21. Estimated completion is 2024-05-28.
What interventions are being tested in trial NCT05824754?
The interventions under investigation include: Just-In-Time-Adaptive-Intervention (JITAI) (OTHER).
Who is sponsoring clinical trial NCT05824754?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05824754's enrollment target sits among peer trials
122 762nd of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03363373 · 122 participants · Phase 2
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
- NCT03463954 · 122 participants · NA
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
- NCT04503265 · 122 participants · Phase 1
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
- NCT04700527 · 122 participants · Phase 1
The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI